在可溶解的微针中含有内拉替尼的固体脂质纳米颗粒,用于增强透皮乳腺癌治疗
Saraisam Kishor Kumar Singha1, Venkatesh Dinnekere Puttegowda2, Yousuf Elbini3
1Department of Pharmaceutics, Acharya & BM Reddy College of Pharmacy, Achit Nagar Post, Dr. Sarvepalli Radhakrishnan Road, Bengaluru, 560107, India.
Drug delivery and translational research
|August 28, 2025
概括
装有内拉替尼固体脂质纳米颗粒 (SLN) 的可溶性微针提供了一种全新的透皮输送系统. 这种方法通过提高药物的疗效和减少副作用来提高乳腺癌的治疗效果.
科学领域:
- 制药科学
- 生物材料工程
- 癌症学
背景情况:
- 尼拉替尼是FDA批准的乳腺癌药物,具有较差的溶解性,有限的透性和全身毒性.
- 通过皮肤输送药物提供了有针对性的治疗和减少副作用的潜力.
研究的目的:
- 开发和表征含有内拉丁尼布固体脂质纳米颗粒 (SLN) 的溶解微针,以增强通过皮肤传递.
- 评估这种用于治疗乳腺癌的新药输送系统的有效性和安全性.
主要方法:
- 使用热同质化来制备内拉替尼载SLN,并以颗粒大小,捕获效率和稳定性进行特征化.
- 通过微型模具将SLN纳入溶解微针中,并评估其物理特性和皮肤透率.
- 在实验室中对MCF-7乳腺癌细胞进行了细胞毒性测试.
主要成果:
- 优化的SLN配方 (F7) 显示颗粒大小为209.4nm,捕获效率为87.57%.
- 外体研究表明药物释放 (80. 71%) 和透到皮肤.
- 与自由的内拉丁尼比相比,内拉丁尼- SLN微针配方在体外对MCF-7细胞的疗效提高.
结论:
- 含有内拉替尼-SLN的可溶性微针是针对性乳腺癌治疗的有前途的透皮策略.
- 这种方法可以提高药物的生物可用性,最大限度地减少全身毒性,并提高患者的服药性.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
Site-Targeted Drug Delivery Systems: Polymeric Carriers
114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114
Transdermal Drug Delivery Systems
157
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
157


